Common Contracts
4 similar Registration Rights Agreement contracts by Y-mAbs Therapeutics, Inc.
EX-4.3(B) 8 a2236551zex-4_3b.htm EX-4.3(B) EXECUTION COPY REGISTRATION RIGHTS AGREEMENT DATED AS OF NOVEMBER 17, 2017 BY AND AMONG Y-MABS THERAPEUTICS, INC., WECO GROUP A/S, MARK UNGER AND LAMBERTO ANDREOTTI REVOCABLE TRUST PageRegistration Rights Agreement • May 5th, 2020 • New York
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • August 24th, 2018 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made as of November 17, 2017, by and among Y-mAbs Therapeutics, Inc., a Delaware corporation (the “Company”), HBM Healthcare Investments (Cayman) Ltd., a Cayman Islands exempt company (“HBM”), Scopia Health Care LLC, a Delaware limited liability company (“Scopia LLC”), Scopia Health Care International Master Fund LP, a Bermuda limited partnership (“Scopia LP”) and Sofinova Venture Partners X, L.P., a Delaware limited partnership (“Sofinnova”). HBM, Scopia LLC, Scopia LP and Sofinnova are also sometimes collectively referred to herein as the “Investors” and individually as an “Investor”. The Investors are also sometimes collectively referred to herein as the “Stockholders” and individually as a “Stockholder.” Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
REGISTRATION RIGHTS AGREEMENT DATED AS OF NOVEMBER 17, 2017 BY AND BETWEEN Y-MABS THERAPEUTICS, INC., AND IVAN SEBASTIAN FERNANDEZ DE MIGUEL GARCIARegistration Rights Agreement • August 24th, 2018 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made as of November 17, 2017, by and between Y-mAbs Therapeutics, Inc., a Delaware corporation (the “Company”) and Ivan Sebastian Fernandez De Miguel Garcia (the “Investor” or the “Stockholder”), residing at Paseo de Alcobendas 14, chalet 4, Alcobendas 28109, Madrid, Spain. Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
REGISTRATION RIGHTS AGREEMENT DATED AS OF NOVEMBER 17, 2017 BY AND AMONG Y-MABS THERAPEUTICS, INC., WECO GROUP A/S, MARK UNGER AND LAMBERTO ANDREOTTI REVOCABLE TRUSTRegistration Rights Agreement • August 24th, 2018 • Y-mAbs Therapeutics, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made as of November 17, 2017, by and among Y-mAbs Therapeutics, Inc., a Delaware corporation (the “Company”), WECO GROUP A/S, a Danish Corporation (“Weco”), having its principal place of business located at Rungsted Strandvej 113, DK 2960, Rungsted Kyst, Denmark, MARK UNGER, residing at 82 Russell Road, Bethany, CT 06524 (“Unger”), and LAMBERTO ANDREOTTI REVOCABLE TRUST (“Andreotti”), having its principal place of business is at 1 West 64th Street, Apt. 12A, New York, NY 10023. Weco, Unger and Andreotti are also sometimes collectively referred to herein as the “Investors” and individually as an “Investor”. The Investors are also sometimes collectively referred to herein as the “Stockholders” and individually as a “Stockholder.” Unless otherwise defined herein, capitalized terms used in this Agreement have the meanings ascribed to them in Section 1.
